(GRAL) GRAIL - Performance 219.2% in 12m
GRAL performance: live returns, drawdowns, peer ranking & SPY comparison from 1w to 5y, all in one clean chart-driven dashboard.
Performance Rating
47.50%
#11 in Peer-Group
Rel. Strength
97.76%
#167 in Stock-Universe
Total Return 12m
219.20%
#6 in Peer-Group
Total Return 5y
138.14%
#9 in Peer-Group
| P/E | Value |
|---|---|
| P/E Trailing | - |
| P/E Forward | - |
| High / Low | USD |
|---|---|
| 52 Week High | 55.02 USD |
| 52 Week Low | 12.57 USD |
| Sentiment | Value |
|---|---|
| VRO Trend Strength +-100 | 72.58 |
| Buy/Sell Signal +-5 | 0.50 |
| Support / Resistance | Levels |
|---|---|
| Support | |
| Resistance |
12m Total Return: GRAL (219.2%) vs XBI (-10.6%)
5y Drawdown (Underwater) Chart
Top Performer in Biotechnology
Overall best picks of Peer Group - Selected by proven GARP Predictive Metrics, sorted by Growth Rating
| Symbol | 1m | 12m | 5y | P/E | P/E Forward | PEG | EPS Stability | EPS CAGR |
|---|---|---|---|---|---|---|---|---|
| GILD NASDAQ Gilead Sciences |
2.17% | 66% | 81.3% | 22.7 | 13.6 | 0.23 | 28.3% | -3.71% |
| UTHR NASDAQ United Therapeutics |
-9.71% | -10.3% | 137% | 11.3 | 10.5 | 1.43 | 74.6% | 16.1% |
| AMGN NASDAQ Amgen |
-0.83% | -8.8% | 39.9% | 26.4 | 13.9 | 0.96 | 0.60% | 41% |
| BIM PA Biomerieux |
1.94% | 32.9% | 4.38% | 33.1 | 25.8 | 1.55 | -38.5% | -25.1% |
| KMDA NASDAQ Kamada |
10.9% | 57.2% | 3.4% | 25.5 | 22.8 | 0.91 | 48.1% | 3.93% |
| NBIX NASDAQ Neurocrine Biosciences |
2.27% | -6.62% | -0.06% | 43 | 24.8 | 0.27 | 18.7% | -34.3% |
| PTCT NASDAQ PTC Therapeutics |
4.14% | 43.8% | -1.58% | 7.71 | 6.26 | 0.81 | - | 68% |
| ERF PA Eurofins Scientific SE |
7.68% | 32.4% | 16% | 28.9 | 15.1 | 0.63 | -62.1% | -19.3% |
Performance Comparison: GRAL vs XBI vs S&P 500
XBI (SPDR S&P Biotech ETF) is the Sector Benchmark for GRAL
| Total Return (including Dividends) | GRAL | XBI | S&P 500 |
|---|---|---|---|
| 1 Month | 14.29% | 4.69% | 4.33% |
| 3 Months | 69.31% | -2.94% | 8.76% |
| 12 Months | 219.20% | -10.58% | 13.95% |
| 5 Years | 138.14% | -24.51% | 116.91% |
| Trend Score (consistency of price movement) | GRAL | XBI | S&P 500 |
|---|---|---|---|
| 1 Month | 88.3% | 30.9% | 79.1% |
| 3 Months | 92.9% | 63.2% | 91.7% |
| 12 Months | 83.5% | -83.8% | 44% |
| 5 Years | 82% | -52.9% | 84% |
| Relative Strength (compared with Indexes) | Rank in Peer Group | vs. XBI | vs. S&P 500 |
|---|---|---|---|
| 1 Month | %th74.50 | 9.17% | 9.55% |
| 3 Month | %th96.00 | 74.44% | 55.68% |
| 12 Month | %th97.50 | 256.96% | 180.12% |
| 5 Years | %th94.00 | 157.47% | 108.56% |
FAQs
Does GRAIL (GRAL) outperform the market?
Yes,
over the last 12 months GRAL made 219.20%, while its related Sector, the SPDR S&P Biotech (XBI) made -10.58%.
Over the last 3 months GRAL made 69.31%, while XBI made -2.94%.
Performance Comparison GRAL vs Indeces and Sectors
Above 0 means better perfomance compared to Symbol in this Timeframe
GRAL vs. Indices
| Symbol | 1w | 1m | 6m | 12m | |
|---|---|---|---|---|---|
| US S&P 500 | SPY | 2.6% | 10% | 142.9% | 205% |
| US NASDAQ 100 | QQQ | 1.9% | 9% | 141.7% | 205% |
| German DAX 40 | DAX | 3.1% | 15.1% | 127% | 188% |
| Shanghai Shenzhen CSI 300 | CSI 300 | 3.8% | 11.4% | 145.7% | 202% |
| Hongkong Hang Seng | HSI | 1.3% | 6.9% | 125.5% | 183% |
| India NIFTY 50 | INDA | 2.4% | 11.9% | 141.7% | 218% |
| Brasil Bovespa | EWZ | 4.4% | 11.9% | 119.8% | 211% |
GRAL vs. Sectors
| Symbol | 1w | 1m | 6m | 12m | |
|---|---|---|---|---|---|
| Communication Services | XLC | 1.1% | 8.3% | 136.6% | 193% |
| Consumer Discretionary | XLY | 2.1% | 13.3% | 151.3% | 200% |
| Consumer Staples | XLP | 6% | 15.8% | 144.1% | 212% |
| Energy | XLE | 9.4% | 10.3% | 144.4% | 222% |
| Financial | XLF | 2.6% | 12% | 139.6% | 191% |
| Health Care | XLV | 4.6% | 12.5% | 149.7% | 226% |
| Industrial | XLI | 2.6% | 11.6% | 136.1% | 197% |
| Materials | XLB | 3.8% | 13% | 142.4% | 218% |
| Real Estate | XLRE | 6.9% | 13.9% | 143.9% | 208% |
| Technology | XLK | 1.6% | 6.1% | 140.9% | 208% |
| Utilities | XLU | 4.7% | 14% | 138.5% | 198% |
| Aerospace & Defense | XAR | 0.4% | 5.3% | 122.5% | 169% |
| Biotech | XBI | 5.3% | 9.6% | 156% | 230% |
| Homebuilder | XHB | 2% | 12.3% | 152.6% | 221% |
| Retail | XRT | 5.3% | 12.8% | 150.7% | 214% |
GRAL vs. Commodities
| Symbol | 1w | 1m | 6m | 12m | |
|---|---|---|---|---|---|
| Oil | USO | 17.9% | 5.37% | 148% | 228% |
| Natural Gas | UNG | 12.4% | 17.4% | 141.9% | 227% |
| Gold | GLD | 8.9% | 15.4% | 122.1% | 179% |
| Silver | SLV | 6.4% | 6.4% | 125% | 196% |
| Copper | CPER | 1.5% | 7.5% | 124.1% | 202% |
GRAL vs. Bonds
| Symbol | 1w | 1m | 6m | 12m | |
|---|---|---|---|---|---|
| iShares 20+ Years Bond | TLT | 5% | 12% | 144.8% | 222% |
| iShares High Yield Corp. Bond | HYG | 5.4% | 12.7% | 142.1% | 209% |